- $21.41bn
- $26.46bn
- $6.07bn
Annual income statement for Equifax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,924 | 5,122 | 5,265 | 5,681 | 6,075 |
| Cost of Revenue | |||||
| Gross Profit | 2,943 | 2,945 | 2,930 | 3,162 | 3,429 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,786 | 4,066 | 4,332 | 4,639 | 4,979 |
| Operating Profit | 1,138 | 1,056 | 934 | 1,042 | 1,095 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 949 | 930 | 718 | 811 | 895 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 749 | 700 | 552 | 607 | 664 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 744 | 696 | 545 | 604 | 660 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 744 | 696 | 545 | 604 | 660 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 6.08 | 5.79 | 4.63 | 5.12 | 5.62 |
| Dividends per Share |